A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML. Issue 13 (10th November 2022) - Lontos, Konstantinos; Tsagianni, Anastasia; Agha, Mounzer; Raptis, Anastasios; Hou, Jing-Zhou; Farah, Rafic; Redner, Robert L.; Im, Annie; Dorritie, Kathleen A.; Sehgal, Alison; Rossetti, James; Aggarwal, Nidhi; et al.